Repopulating defect of mismatch repair-deficient hematopoietic stem cells

Blood

Volumn 102, Issue 5, 2003, Pages 1626-1633

  Reese, Jane S ^b   Liu, Lili ^b   Gerson, Stanton L ^a  

^a BRB   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN LIN; PROTEIN MSH2; PROTEIN SCA; STEM CELL FACTOR; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CELL REGENERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG TOLERANCE; HEMATOPOIETIC STEM CELL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; TELOMERE;

EID: 0041440074     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3035     Document Type: Article

References (41)

1. Eadie JS, Conrad M, Toorchen D, Topal MD. Mechanism of mutagenesis by O6-methylguanine. Nature. 1984;308:201-203.
2. Karran P, Bignami M. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res. 1992;20:2933-2940.
3. Hickman MJ, Samson LD. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A. 1999;96:10764-10769.
4. de Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse MSH2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 1995;82:321-330.
5. Boyer JC, Umar A, Risinger JI, et al. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res. 1995;55:6063-6070.
6. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell. 1993;75:1227-1236.
7. Eshleman JR, Lang EZ, Bowerfind GK, et al. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene. 1995;10:33-37.
8. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994;368:258-261.
9. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75:1027-1038.
10. Kodera T, Kohno T, Takakura S, et al. Microsatellite instability in lymphoid leukemia and lymphoma cell lines but not in myeloid leukemia cell lines. Genes Chromosomes Cancer. 1999;26: 267-269.
11. Levati L, Marra G, Lettieri T, et al. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer. 1998;23: 159-166.
12. Tasaka T, Lee S, Spira S, et al. Microsatellite instability during the progression of acute myelocytic leukaemia. Br J Haematol. 1997;98:219-221.
13. Zhu YM, Das-Gupta EP, Russell NH. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood. 1999;94:733-740.
14. Rimsza LM, Kopecky KJ, Ruschulte J, et al. Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature. Leukemia. 2000;14: 1044-1051.
15. Ben-Yehuda D, Krichevsky S, Caspi O, et al. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood. 1996;88:4296-4303.
16. Whiteside D, McLeod R, Graham G, et al. A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res. 2002;62:359-362.
17. Reitmair AH, Schmits R, Ewel A, et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet. 1995;11:64-70.
18. Gothot A, Pyatt R, McMahel J, Rice S, Srour EF. Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0. Exp Hematol. 1998;26:562-570.
19. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743-747.
20. Provost GS, Kretz PL, Hamner RT, Matthews CD, Rogers BJ, Lundberg KS, Dycaico MJ, Short JM. Transgenic systems for in vivo mutation analysis. Mutat Res. 1993;288:133-149.
21. Reitmair AH, Risley R, Bristow RG, et al. Mutator phenotype in MSH2-/-deficient murine embryonic fibroblasts. Cancer Res. 1997;57:3765-3771.
22. Reese JS, Qin X, Ballas CB, Sekiguchi M, Gerson SL. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure. J Hematother Stem Cell Res. 2001;10:115-123.
23. Kawate H, Sakumi K, Tsuzuki T, et al. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc Natl Acad Sci U S A. 1998;95:5116-5120.
24. Dumenco LL, Allay E, Norton K, Gerson SL. The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science. 1993;259:219-222.
25. Carreau M, Gan OI, Liu L, et al. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage. Blood. 1998;91:2737-2744.
26. Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med. 2000;6:1235-1240.
27. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21 cip1/waf1. Science. 2000;287:1804-1808.
28. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med. 2001;193:917-924.
29. Zhang S, Lloyd R, Bowden G, Glickman BW, de Boer JG. Thymic lymphomas arising in MSH2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum. Mutat Res. 2002;500:67-74.
30. Baker SM, Bronner CE, Zhang L, et al. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 1995;82:309-319.
31. Shao C, Yin M, Deng L, Stambrook PJ, Doetschman T, Tischfield JA. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of PMS2-/- mice. Oncogene. 2002;21: 2840-2845.
32. Frey S, Bertocci B, Delbos F, Quint L, Weill JC, Reynaud CA. Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process. Immunity. 1998;9:127-134.
33. Vassileva V, Millar A, Briollais L, Chapman W, Bapat B. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Research. 2002;62: 4095-4099.
34. Qin X, Liu L, Gerson SL. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT. Oncogene. 1999;18:4394-4400.
35. Qin X, Zhou H, Liu L, Gerson SL. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis. 1999; 20:1667-1673.
36. Sill H, Aguiar RC, Schmidt H, Hochhaus A, Goldman JM, Cross NC. Mutational analysis of the p15 and p16 genes in acute leukaemias. Br J Haematol. 1996;92:681-683.
37. Chen R, Nagarajan S, Prince GM, et al. Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2000;106: 689-696.
38. Tsao JL, Davis SD, Baker SM, Liskay RM, Shibata D. Intestinal stem cell division and genetic diversity. A computer and experimental analysis. Am J Pathol. 1997;151:573-579.
39. Baross-Francis A, Makhani N, Liskay RM, Jirik FR. Elevated mutant frequencies and increased C: G → T: A transitions in Mlh1-/-versus PMS2-/-murine small intestinal epithelial cells. Oncogene. 2001;20:619-625.
40. Baker SM, Plug AW, Prolla TA, et al. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet. 1996;13:336-342.
41. Edelmann W, Cohen PE, Kane M, et al. Meiotic pachytene arrest in MLH1-deficient mice. Cell. 1996;85:1125-1134.